{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:13:13Z","timestamp":1790190793236,"version":"4.1.0"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jns.2019.116428","type":"journal-article","created":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T11:26:40Z","timestamp":1565954800000},"page":"116428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Myasthenia gravis: Historical achievements and the \u201cgolden age\u201d of clinical trials"],"prefix":"10.1016","volume":"406","author":[{"given":"Tam M.","family":"Nguyen-Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Gelinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Mondou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2019.116428_bb0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in myasthenia gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol."},{"issue":"1","key":"10.1016\/j.jns.2019.116428_bb0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3233\/JND-140045","article-title":"The epidemiology of neuromuscular disorders: a comprehensive overview of the literature","volume":"2","author":"Deenen","year":"2015","journal-title":"J. Neuromuscul. Dis."},{"issue":"2","key":"10.1016\/j.jns.2019.116428_bb0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis","volume":"37","author":"Grob","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2019.116428_bb0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/ane.12233","article-title":"Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries","volume":"198","author":"Andersen","year":"2014","journal-title":"Acta Neurol. Scand. Suppl."},{"issue":"4","key":"10.1016\/j.jns.2019.116428_bb0025","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1600-0404.1984.tb00825.x","article-title":"Epidemiology of myasthenia gravis in Norway","volume":"70","author":"Storm-Mathisen","year":"1984","journal-title":"Acta Neurol. Scand."},{"issue":"3","key":"10.1016\/j.jns.2019.116428_bb0030","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-0404.1999.tb00733.x","article-title":"Epidemiological and clinical characteristics of myasthenia gravis in Belgrade, Yugoslavia (1983-1992)","volume":"100","author":"Lavrnic","year":"1999","journal-title":"Acta Neurol. Scand."},{"issue":"4","key":"10.1016\/j.jns.2019.116428_bb0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000109688","article-title":"Epidemiology of myasthenia gravis in northwestern Sardinia","volume":"16","author":"Aiello","year":"1997","journal-title":"Neuroepidemiology"},{"issue":"4","key":"10.1016\/j.jns.2019.116428_bb0040","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1600-0404.1989.tb03793.x","article-title":"Epidemiological study of myasthenia gravis in Sardinia, Italy (1958-1986)","volume":"79","author":"Giagheddu","year":"1989","journal-title":"Acta Neurol. Scand."},{"issue":"2","key":"10.1016\/j.jns.2019.116428_bb0045","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1212\/WNL.0b013e3181ad53c2","article-title":"Seropositive myasthenia gravis: a nationwide epidemiologic study","volume":"73","author":"Heldal","year":"2009","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.jns.2019.116428_bb0050","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archneur.1991.00530190081019","article-title":"Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey","volume":"48","author":"Somnier","year":"1991","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2019.116428_bb0055","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/ane.12271","article-title":"Antititin antibody in early- and late-onset myasthenia gravis","volume":"130","author":"Szczudlik","year":"2014","journal-title":"Acta Neurol. Scand."},{"issue":"4","key":"10.1016\/j.jns.2019.116428_bb0060","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000328863","article-title":"Change in myasthenia gravis epidemiology in Trento, Italy, after twenty years","volume":"36","author":"Pallaver","year":"2011","journal-title":"Neuroepidemiology"},{"issue":"5","key":"10.1016\/j.jns.2019.116428_bb0065","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis - autoantibody characteristics and their implications for therapy","volume":"12","author":"Gilhus","year":"2016","journal-title":"Nat. Rev. Neurol."},{"issue":"26","key":"10.1016\/j.jns.2019.116428_bb0070","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jns.2019.116428_bb0075","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"Pt 17","key":"10.1016\/j.jns.2019.116428_bb0080","first-page":"3110","article-title":"Titin force enhancement following active stretch of skinned skeletal muscle fibres","volume":"220","author":"Powers","year":"2017","journal-title":"J. Exp. Biol."},{"issue":"9","key":"10.1016\/j.jns.2019.116428_bb0085","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1212\/WNL.57.9.1579","article-title":"Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?","volume":"57","author":"Buckley","year":"2001","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jns.2019.116428_bb0090","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archneur.58.6.885","article-title":"Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients","volume":"58","author":"Yamamoto","year":"2001","journal-title":"Arch. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2019.116428_bb0095","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s004150050604","article-title":"Muscle autoantibodies in subgroups of myasthenia gravis patients","volume":"247","author":"Romi","year":"2000","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2019.116428_bb0100","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/ane.13071","article-title":"Autoantibodies in acquired myasthenia gravis: clinical phenotype and immunological correlation","volume":"139","author":"Nagappa","year":"2019","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2019.116428_bb0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coi.2017.07.006","article-title":"Pathophysiology and immunological profile of myasthenia gravis and its subgroups","volume":"49","author":"Romi","year":"2017","journal-title":"Curr. Opin. Immunol."},{"issue":"11","key":"10.1016\/j.jns.2019.116428_bb0110","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1001\/archneur.57.11.1596","article-title":"The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies","volume":"57","author":"Romi","year":"2000","journal-title":"Arch. Neurol."},{"issue":"7","key":"10.1016\/j.jns.2019.116428_bb0115","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/jnnp.57.7.843","article-title":"Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis","volume":"57","author":"Mygland","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.jns.2019.116428_bb0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/archneur.1988.00520260073024","article-title":"The first American case of myasthenia gravis","volume":"45","author":"Marsteller","year":"1988","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2019.116428_bb0125","author":"Willis","year":"1672"},{"key":"10.1016\/j.jns.2019.116428_bb0130","author":"Willis","year":"1685"},{"issue":"5897","key":"10.1016\/j.jns.2019.116428_bb0135","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/301251a0","article-title":"Primary structures of beta- and delta-subunit precursors of Torpedo californica acetylcholine receptor deduced from cDNA sequences","volume":"301","author":"Noda","year":"1983","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jns.2019.116428_bb0140","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1432-1033.1993.tb18027.x","article-title":"Primary structure of the human muscle acetylcholine receptor. cDNA cloning of the gamma and epsilon subunits","volume":"215","author":"Beeson","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jns.2019.116428_bb0145","series-title":"Guy's Hospital Reports","first-page":"7","article-title":"On cerebritis, hysteria, and bulbar paralysis","volume":"22","author":"Wilks","year":"1877"},{"key":"10.1016\/j.jns.2019.116428_bb0150","first-page":"337","article-title":"Ein Fall von Ophthalmoplegia externa progressiva und finaler Bulbarparalyse mit negativem Sectionsbefund","volume":"15","author":"Eisenlohr","year":"1887","journal-title":"Neurologisches Centralblatt"},{"key":"10.1016\/j.jns.2019.116428_bb0155","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/brain\/13.1.96","article-title":"A case of bulbar paralysis without structural changes in the medulla","volume":"13","author":"Shaw","year":"1890","journal-title":"Brain"},{"key":"10.1016\/j.jns.2019.116428_bb0160","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF02666475","article-title":"Zur Casuistik der bulb\u00e4ren L\u00e4hmungen","volume":"9","author":"Erb","year":"1879","journal-title":"Arch. Psychiat. Nervenkr."},{"key":"10.1016\/j.jns.2019.116428_bb0165","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/BF01665294","article-title":"Ueber einen scheinbar heilbaren bulb\u00e4rparalytischen Symptomencomplex mit Betheiligung der Extremit\u00e4ten","volume":"4","author":"Goldflam","year":"1893","journal-title":"Deutsche Zeitschrift f\u00fcr Nervenheilkunde"},{"key":"10.1016\/j.jns.2019.116428_bb0170","first-page":"1","article-title":"Ueber myasthenia gravis pseudoparalytica","volume":"32","author":"Jolly","year":"1895","journal-title":"Berliner Klinische Wochenschrift"},{"issue":"7","key":"10.1016\/j.jns.2019.116428_bb0175","first-page":"722","article-title":"Myasthenia gravis: a case in which fatigue of the forearm muscles could induce paralysis of the extra-ocular muscles","volume":"31","author":"Walker","year":"1938","journal-title":"Proc. R. Soc. Med."},{"key":"10.1016\/j.jns.2019.116428_bb0180","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1017\/S0025727300026612","article-title":"The history of myasthenia gravis","volume":"5","author":"Keynes","year":"1961","journal-title":"Med. Hist."},{"key":"10.1016\/j.jns.2019.116428_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01668207","article-title":"Weiterer Beitrag zur Lehre von der acuten, nicht-eitrigen Encephalitis und der Poliencephalomyelitis","volume":"15","author":"Oppenheim","year":"1899","journal-title":"Deutsch Zeit f Nervenheilkunde"},{"key":"10.1016\/j.jns.2019.116428_bb0190","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00005053-189909000-00002","article-title":"Asthenic bulbar paralysis","volume":"26","author":"Sinkler","year":"1899","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.jns.2019.116428_bb0195","series-title":"The Principles and Practice of Medicine","author":"Osler","year":"1899"},{"key":"10.1016\/j.jns.2019.116428_bb0200","series-title":"The Principles and Practice of Medicine","author":"Osler","year":"1901"},{"issue":"2","key":"10.1016\/j.jns.2019.116428_bb0205","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/brain\/23.2.277","article-title":"Myasthenia gravis","volume":"23","author":"Campbell","year":"1900","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.jns.2019.116428_bb0210","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/00005053-191211000-00001","article-title":"Myasthenia gravis","volume":"39","author":"Starr","year":"1912","journal-title":"J. Nerv. Mcnt. Dis."},{"key":"10.1016\/j.jns.2019.116428_bb0215","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF01669851","article-title":"Ueber die asthenische Bulb\u00e4rparalyse (Bulb\u00e4rparalyse ohne anatomischen Befund, Myasthenia gravis pseudoparalytica) [On the asthenic Bulbar paralysis (Bulbar paralysis without anatomical findings, Myasthenia gravis pseudoparalytica)]","volume":"8","author":"St\u00fcmpell","year":"1896","journal-title":"Deutsch Zeit. f. Nervenheilkunde"},{"key":"10.1016\/j.jns.2019.116428_bb0220","first-page":"596","article-title":"Pathologisch-anatomischer Beitrag zur Erb'schen Krankheit (Myasthenia gravis). [Pathological-anatomical contribution to Erb's disease (myasthenia gravis)]","author":"Weigert","year":"1901","journal-title":"Neurologisches Centralblatt"},{"key":"10.1016\/j.jns.2019.116428_bb0225","first-page":"746","article-title":"Thymektomie bei einem Fall von Morbus Basedowi mit Myasthenie [Thymectomy in a case of Graves' Disease with myasthenia]","volume":"25","author":"Schumacher","year":"1912","journal-title":"Mitt. Grenzgeb. Med. Chir."},{"issue":"4","key":"10.1016\/j.jns.2019.116428_bb0230","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00000658-193910000-00005","article-title":"Myasthenia gravis and tumors of the thymic region: report of a case in which the tumor was removed","volume":"110","author":"Blalock","year":"1939","journal-title":"Ann. Surg."},{"issue":"5","key":"10.1016\/j.jns.2019.116428_bb0235","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/00000658-194105000-00002","article-title":"Blood and blood substitutes in the treatment and prevention of shock: with particular reference to their uses in warfare","volume":"113","author":"Blalock","year":"1941","journal-title":"Ann. Surg."},{"issue":"4628","key":"10.1016\/j.jns.2019.116428_bb0240","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/bmj.2.4628.611","article-title":"The results of thymectomy in myasthenia gravis","volume":"2","author":"Keynes","year":"1949","journal-title":"Br. Med. J."},{"issue":"13","key":"10.1016\/j.jns.2019.116428_bb0245","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jama.1950.02910310007002","article-title":"Thymectomy in the treatment of myasthenia gravis","volume":"142","author":"Eaton","year":"1950","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.jns.2019.116428_bb0250","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jama.1957.02970480021005","article-title":"Electromyography and electric stimulation of nerves in diseases of motor unit; observations on myasthenic syndrome associated with malignant tumors","volume":"163","author":"Eaton","year":"1957","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.jns.2019.116428_bb0255","series-title":"Myathenia Gravis: An Illustrated History","author":"Keesey","year":"2002"},{"issue":"5\u20136","key":"10.1016\/j.jns.2019.116428_bb0260","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1113\/jphysiol.1907.sp001198","article-title":"The innervation of the bladder and urethra","volume":"35","author":"Elliott","year":"1907","journal-title":"J. Physiol."},{"key":"10.1016\/j.jns.2019.116428_bb0265","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF01722758","article-title":"\u00dcber humorale \u00dcbertragbarkeit der Herznervenwirkung","volume":"206","author":"Loewi","year":"1924","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.jns.2019.116428_bb0270","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF01738910","article-title":"\u00dcber humorale \u00dcbertragbarkeit der Herznervenwirkung. I.Mitteilung","volume":"189","author":"O","year":"1921","journal-title":"Pflugers Arch."},{"issue":"7","key":"10.1016\/j.jns.2019.116428_bb0275","first-page":"379","article-title":"Transmission of nervous effects by acetylcholine: Harvey lecture, May 20, 1937","volume":"13","author":"Dale","year":"1937","journal-title":"Bull. N. Y. Acad. Med."},{"issue":"15","key":"10.1016\/j.jns.2019.116428_bb0280","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/jama.1930.27120410003009c","article-title":"A report of progress on the use of ephedrine in a case of myasthenia gravis","volume":"94","author":"Edgeworth","year":"1930","journal-title":"J. Am. Med. Assoc."},{"issue":"18","key":"10.1016\/j.jns.2019.116428_bb0285","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/jama.1933.27420180001007","article-title":"The effects of ephedrine in the treatment of myasthenia gravis: second report","volume":"100","author":"Edgeworth","year":"1933","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.jns.2019.116428_bb0290","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0140-6736(00)94294-6","article-title":"Treatment of myasthenia gravis with physostigmine","volume":"1","author":"Walker","year":"1934","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jns.2019.116428_bb0295","volume":"69","author":"Harvey","year":"1941","journal-title":"Bull. Johns Hopkins Hosp."},{"issue":"1","key":"10.1016\/j.jns.2019.116428_bb0300","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1113\/jphysiol.1952.sp004735","article-title":"Spontaneous subthreshold activity at motor nerve endings","volume":"117","author":"Fatt","year":"1952","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.jns.2019.116428_bb0305","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1113\/jphysiol.1964.sp007495","article-title":"An electrophysiological investigation of neuro-muscular transmission in myasthenia gravis","volume":"174","author":"Elmqvist","year":"1964","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.jns.2019.116428_bb0310","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0368-2242(59)80003-8","article-title":"Tumours of the thyroid gland in relation to some general concepts of neoplasia","volume":"10","author":"Smithers","year":"1959","journal-title":"J. Fac. Radiol."},{"issue":"10","key":"10.1016\/j.jns.2019.116428_bb0315","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/003693306000501001","article-title":"Myasthenia gravis: a new hypothesis","volume":"5","author":"Simpson","year":"1960","journal-title":"Scott. Med. J."},{"issue":"3","key":"10.1016\/j.jns.2019.116428_bb0320","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0002-9343(59)90248-7","article-title":"Search for a neuromuscular blocking agent in the blood of patients with myasthenia gravis","volume":"26","author":"Nastuk","year":"1959","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jns.2019.116428_bb0325","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3181\/00379727-105-26050","article-title":"Changes in serum complement activity in patients with myasthenia gravis","volume":"105","author":"Nastuk","year":"1960","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"8","key":"10.1016\/j.jns.2019.116428_bb0330","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1212\/WNL.26.8.729","article-title":"Long-term administration of corticosteroids in myasthenia gravis","volume":"26","author":"Mann","year":"1976","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2019.116428_bb0335","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0733-8619(18)30101-4","article-title":"The treatment of patients with myasthenia gravis","volume":"12","author":"Sanders","year":"1994","journal-title":"Neurol. Clin."},{"issue":"4109","key":"10.1016\/j.jns.2019.116428_bb0340","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1126\/science.182.4109.293","article-title":"Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors","volume":"182","author":"Fambrough","year":"1973","journal-title":"Science"},{"issue":"4088","key":"10.1016\/j.jns.2019.116428_bb0345","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.jns.2019.116428_bb0350","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.116428_bb0355","series-title":"Plasmapheresis and the Immunobiology of Myasthenia Gravis: Proceedings of a Symposium","first-page":"144","article-title":"Studies in myasthenia gravis: staging and gamma globulin","author":"Genkins","year":"1979"},{"issue":"8373","key":"10.1016\/j.jns.2019.116428_bb0360","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0140-6736(84)90469-0","article-title":"High-dose intravenous gammaglobulin for myasthenia gravis","volume":"1","author":"Gajdos","year":"1984","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jns.2019.116428_bb0365","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/archinte.1986.00360190143020","article-title":"High-dose intravenous immunoglobulin in the management of myasthenia gravis","volume":"146","author":"Arsura","year":"1986","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"10.1016\/j.jns.2019.116428_bb0370","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: executive summary","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.116428_bb0375","series-title":"The Quantitative Myasthenia Gravis (QMG) Test The Manual","author":"Barohn","year":"2000"},{"issue":"12","key":"10.1016\/j.jns.2019.116428_bb0380","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","article-title":"Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study","volume":"16","author":"Howard","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2019.116428_bb0385","series-title":"FDA Approves Soliris\u00ae (Eculizumab) for the Treatment of Patients with Generalized Myasthenia Gravis (gMG)","author":"Alexion Pharmaceuticals, I","year":"2017"},{"key":"10.1016\/j.jns.2019.116428_bb0390","series-title":"SOLIRIS\u00ae (eculizumab) injection, for intravenous use [package insert]","year":"2017"},{"issue":"6","key":"10.1016\/j.jns.2019.116428_bb0395","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jns.2019.116428_bb0400","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1515\/revneuro-2014-0021","article-title":"Targeting complement system to treat myasthenia gravis","volume":"25","author":"Huda","year":"2014","journal-title":"Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.jns.2019.116428_bb0405","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/mus.23839","article-title":"A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis","volume":"48","author":"Howard","year":"2013","journal-title":"Muscle Nerve"},{"issue":"10","key":"10.1016\/j.jns.2019.116428_bb0410","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/nbt1143","article-title":"Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels","volume":"23","author":"Vaccaro","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jns.2019.116428_bb0415","series-title":"15th International Congress on Neuromuscular Diseases","article-title":"A double-blind, placebo-controlled study to evaluate safety and efficacy of FcRn-antagonist ARGX-113 in generalized MG","author":"Verschuuren","year":"2018"},{"key":"10.1016\/j.jns.2019.116428_bb0420","article-title":"Intravenous immunoglobulin for myasthenia gravis","volume":"12","author":"Gajdos","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.jns.2019.116428_bb0425","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.410410615","article-title":"Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group","volume":"41","author":"Gajdos","year":"1997","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.jns.2019.116428_bb0430","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/archneur.62.11.1689","article-title":"Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: a randomized double-blind clinical trial","volume":"62","author":"Gajdos","year":"2005","journal-title":"Arch. Neurol."},{"issue":"11","key":"10.1016\/j.jns.2019.116428_bb0435","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1212\/01.wnl.0000256698.69121.45","article-title":"IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trial","volume":"68","author":"Zinman","year":"2007","journal-title":"Neurology"},{"issue":"23","key":"10.1016\/j.jns.2019.116428_bb0440","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1212\/WNL.0b013e31821e5505","article-title":"Comparison of IVIg and PLEX in patients with myasthenia gravis","volume":"76","author":"Barth","year":"2011","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2019.116428_bb0450","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2249.1990.tb05440.x","article-title":"Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin","volume":"82","author":"Aarli","year":"1990","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.jns.2019.116428_bb0455","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jns.2019.116428_bb0460","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/mus.1218","article-title":"The agrin\/muscle-specific kinase pathway: new targets for autoimmune and genetic disorders at the neuromuscular junction","volume":"25","author":"Liyanage","year":"2002","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.jns.2019.116428_bb0465","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/jama.1969.03160190028006","article-title":"Studies in myasthenia gravis. Transcervical total thymectomy","volume":"209","author":"Kirschner","year":"1969","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jns.2019.116428_bb0470","first-page":"53","article-title":"Combined cervicothoracic approach in thymectomy for myasthenia gravis","volume":"156","author":"Lennquist","year":"1990","journal-title":"Acta Chir. Scand."},{"issue":"5","key":"10.1016\/j.jns.2019.116428_bb0475","first-page":"408","article-title":"Mediastinoscopy auxiliary to thymectomy by the cervical route","volume":"17","author":"Carlens","year":"1967","journal-title":"Bronches"},{"issue":"6","key":"10.1016\/j.jns.2019.116428_bb0480","first-page":"759","article-title":"Case showing the effect of prostigmin on myasthenia gravis","volume":"28","author":"Walker","year":"1935","journal-title":"Proc. R. Soc. Med."},{"issue":"3","key":"10.1016\/j.jns.2019.116428_bb0485","first-page":"153","article-title":"Studies in neuromuscular function. IV. Stimulating and depressant effects of acetylcholine and choline in patients with myasthenia gravis, and their relationship to the defect in neuromuscular transmission","volume":"99","author":"Grob","year":"1956","journal-title":"Bull. Johns Hopkins Hosp."},{"issue":"9","key":"10.1016\/j.jns.2019.116428_bb0490","first-page":"701","article-title":"Preliminary observations of the treatment of myasthenia by azathioprine","volume":"67","author":"Delwaide","year":"1967","journal-title":"Acta Neurol. Psychiatr. Belg."},{"issue":"2","key":"10.1016\/j.jns.2019.116428_bb0495","first-page":"161","article-title":"The favourable effect of cyclophosphamide in myasthenia gravis","volume":"13","author":"Nouza","year":"1968","journal-title":"Rev. Fr. Etud. Clin. Biol."},{"issue":"12","key":"10.1016\/j.jns.2019.116428_bb0500","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM198703193161205","article-title":"Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis","volume":"316","author":"Tindall","year":"1987","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jns.2019.116428_bb0505","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1212\/WNL.51.3.912-a","article-title":"Successful treatment of a patient with severe refractory myasthenia gravis using mycophenolate mofetil","volume":"51","author":"Hauser","year":"1998","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.jns.2019.116428_bb0510","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1212\/WNL.55.7.1062-a","article-title":"Rituximab for myasthenia gravis developing after bone marrow transplant","volume":"55","author":"Zaja","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2019.116428_bb0515","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mus.10018","article-title":"Successful treatment of myasthenia gravis with tacrolimus","volume":"25","author":"Evoli","year":"2002","journal-title":"Muscle Nerve"},{"issue":"16","key":"10.1016\/j.jns.2019.116428_bb0520","doi-asserted-by":"crossref","first-page":"e1425","DOI":"10.1212\/WNL.0000000000005323","article-title":"Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis","volume":"90","author":"Hewett","year":"2018","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jns.2019.116428_bb0525","first-page":"531","article-title":"Effect of 'maximum immune suppression' with thoracic duct drainage, ALG, azathioprine and cortisone in some neurological disorders","volume":"65","author":"Brendel","year":"1972","journal-title":"Proc. R. Soc. Med."},{"issue":"5","key":"10.1016\/j.jns.2019.116428_bb0530","doi-asserted-by":"crossref","first-page":"749","DOI":"10.7326\/0003-4819-75-5-749","article-title":"Improvement of myasthenia gravis by hemodialysis in a patient with chronic renal failure","volume":"75","author":"Hedger","year":"1971","journal-title":"Ann. Intern. Med."},{"issue":"8000","key":"10.1016\/j.jns.2019.116428_bb0535","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0140-6736(76)91917-6","article-title":"Remission of myasthenia gravis following plasma-exchange","volume":"2","author":"Pinching","year":"1976","journal-title":"Lancet"},{"issue":"8381","key":"10.1016\/j.jns.2019.116428_bb0540","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(84)92294-3","article-title":"High-dose intravenous gammaglobulin for myasthenia gravis","volume":"1","author":"Fateh-Moghadam","year":"1984","journal-title":"Lancet"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19303600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19303600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:48:22Z","timestamp":1758383302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X19303600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":107,"alternative-id":["S0022510X19303600"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2019.116428","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myasthenia gravis: Historical achievements and the \u201cgolden age\u201d of clinical trials","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2019.116428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116428"}}